Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A B Mehta

Showing results (101-110 of 133) with videos related to

Pageof 14
Sort By:
European Journal of Haematology|November 1, 1995
Identification of latent myeloproliferative disease in patients with Budd-Chiari syndrome using X-chromosome inactivation patterns and in vitro erythroid colony formationJ Acharya, N B Westwood, B M Sawyer, et al.
American Journal of Hematology|June 26, 2001
Multiple myeloma and human immunodeficiency virus-1 (HIV-1) infectionT T Yee, K Murphy, M Johnson, et al.
British Journal of Haematology|February 1, 1992
Increase in 2',5'-oligoadenylate synthetase caused by deoxycoformycin in hairy cell leukaemiaK Ganeshaguru, W C de Mel, G Sissolak, et al.
Clinical and Laboratory Haematology|January 1, 1985
Osteolytic lesion as the presenting feature of chronic granulocytic leukaemiaA B Mehta, J Tavares De Castro, J F San Miguel, et al.
The Journal of Infection|January 1, 1997
Disseminated infection due to Cylindrocarpon lichenicola in a patient with acute myeloid leukaemiaE A James, K Orchard, P H McWhinney, et al.
Leukemia & Lymphoma|July 27, 2016
Recombinant Alpha 2A Interferon-An Effective Maintenance Agent in Essential ThrombocythaemiaF J Giles, C C Anderson, I R Grant, et al.
British Journal of Haematology|August 1, 1990
Malignant plasma cells are sensitive to LAK cell lysis: pre-clinical and clinical studies of interleukin 2 in the treatment of multiple myelomaD J Gottlieb, H G Prentice, A B Mehta, et al.
Plos One|April 6, 2018
Phenotype and biochemical heterogeneity in late onset Fabry disease defined by N215S mutationL Lavalle, A S Thomas, B Beaton, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 28, 2010
Long-term outcomes of liver transplantation in type 1 Gaucher diseaseR M Ayto, D A Hughes, P Jeevaratnam, et al.
Oncogene|May 6, 1999
Ceramide-induced killing of normal and malignant human lymphocytes is by a non-apoptotic mechanismK Mengubas, F A Riordan, C A Bravery, et al.
Pageof 14

Showing results (101-110 of 133) with videos related to

Sort By:
Pageof 14
European Journal of Haematology|November 1, 1995
Identification of latent myeloproliferative disease in patients with Budd-Chiari syndrome using X-chromosome inactivation patterns and in vitro erythroid colony formationJ Acharya, N B Westwood, B M Sawyer, et al.
American Journal of Hematology|June 26, 2001
Multiple myeloma and human immunodeficiency virus-1 (HIV-1) infectionT T Yee, K Murphy, M Johnson, et al.
British Journal of Haematology|February 1, 1992
Increase in 2',5'-oligoadenylate synthetase caused by deoxycoformycin in hairy cell leukaemiaK Ganeshaguru, W C de Mel, G Sissolak, et al.
Clinical and Laboratory Haematology|January 1, 1985
Osteolytic lesion as the presenting feature of chronic granulocytic leukaemiaA B Mehta, J Tavares De Castro, J F San Miguel, et al.
The Journal of Infection|January 1, 1997
Disseminated infection due to Cylindrocarpon lichenicola in a patient with acute myeloid leukaemiaE A James, K Orchard, P H McWhinney, et al.
Leukemia & Lymphoma|July 27, 2016
Recombinant Alpha 2A Interferon-An Effective Maintenance Agent in Essential ThrombocythaemiaF J Giles, C C Anderson, I R Grant, et al.
British Journal of Haematology|August 1, 1990
Malignant plasma cells are sensitive to LAK cell lysis: pre-clinical and clinical studies of interleukin 2 in the treatment of multiple myelomaD J Gottlieb, H G Prentice, A B Mehta, et al.
Plos One|April 6, 2018
Phenotype and biochemical heterogeneity in late onset Fabry disease defined by N215S mutationL Lavalle, A S Thomas, B Beaton, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 28, 2010
Long-term outcomes of liver transplantation in type 1 Gaucher diseaseR M Ayto, D A Hughes, P Jeevaratnam, et al.
Oncogene|May 6, 1999
Ceramide-induced killing of normal and malignant human lymphocytes is by a non-apoptotic mechanismK Mengubas, F A Riordan, C A Bravery, et al.
Pageof 14